After a week scrabbling to calm the EpiPen pricing crisis, Mylan has unveiled its latest tactic. The drugmaker plans to launch an authorized generic priced at…

The Attorney General of New Hampshire is accusing Purdue Pharma of dragging its feet in his investigation into Purdue’s marketing of its highly addictive…

Lately, it seems that photo campaigns are all the rage in pharma marketing. The latest company to start one up? Novartis.

It’s deja vu for the pharma industry. Mylan’s EpiPen pricing controversy--kicked into high gear last week with mainstream media coverage of widespread outrage…

The U.K.’s promotional police cracked down on biosimilar marketing this week, citing Pfizer’s Hospira unit and Napp Pharmaceuticals for code violations at…

After a former Insys Therapeutics sales rep admitted she had paid kickbacks to doctors to prescribe the company's sprayed cancer pain opioid fentanyl for…

It didn’t take long for the backlash to start after Mylan crafted an EpiPen patient-assistance plan to calm the pricing crisis. Critics pounced, calling the…

Novartis is getting closer to unloading its $14 billion stake in crosstown rival Roche. Big investors have been shopping the sale, and bankers could assemble…